These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 34425414)

  • 1. Examination of the protective efficacy of two avian influenza H5 vaccines against clade 2.3.4.4b H5N8 highly pathogenic avian influenza virus in commercial broilers.
    El-Shall NA; Awad AM; Sedeik ME
    Res Vet Sci; 2021 Nov; 140():125-133. PubMed ID: 34425414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection Afforded by a Recombinant Turkey Herpesvirus-H5 Vaccine Against the 2014 European Highly Pathogenic H5N8 Avian Influenza Strain.
    Steensels M; Rauw F; van den Berg T; Marché S; Gardin Y; Palya V; Lambrecht B
    Avian Dis; 2016 May; 60(1 Suppl):202-9. PubMed ID: 27309056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of inactivated avian influenza virus and Newcastle disease virus bivalent vaccination program against newly circulated H5N8 and NDV strains.
    Azab AA; Yehia N; Makhareta M; Samir M; Shoukry A; Elhalem Mohamed AA; Alhag SK; Alwabli AS; El-Saadony MT; El-Tarabily KA; Soliman MA
    Poult Sci; 2023 Oct; 102(10):102952. PubMed ID: 37634266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus.
    Kilany WH; Safwat M; Mohammed SM; Salim A; Fasina FO; Fasanmi OG; Shalaby AG; Dauphin G; Hassan MK; Lubroth J; Jobre YM
    PLoS One; 2016; 11(6):e0156747. PubMed ID: 27304069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effectiveness of rHVT-H5, inactivated H5 and rHVT-H5 with inactivated H5 prime/boost vaccination regimes in commercial broiler chickens carrying MDAs against HPAI H5N1 clade 2.2.1 virus.
    Kilany WH; Hassan MK; Safwat M; Mohammed S; Selim A; VonDobschuetz S; Dauphin G; Lubroth J; Jobre Y
    Avian Pathol; 2015 Oct; 44(5):333-41. PubMed ID: 26023824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a Recombinant Turkey Herpesvirus H5 Vaccine Against Challenge With H5N1 Clades 1.1.2 and 2.3.2.1 Highly Pathogenic Avian Influenza Viruses in Domestic Ducks (Anas platyrhynchos domesticus).
    Pantin-Jackwood MJ; Kapczynski DR; DeJesus E; Costa-Hurtado M; Dauphin G; Tripodi A; Dunn JR; Swayne DE
    Avian Dis; 2016 Mar; 60(1):22-32. PubMed ID: 26953940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of White Leghorn chickens by U.S. emergency H5 vaccination against clade 2.3.4.4 H5N2 high pathogenicity avian influenza virus.
    Bertran K; Balzli C; Lee DH; Suarez DL; Kapczynski DR; Swayne DE
    Vaccine; 2017 Nov; 35(46):6336-6344. PubMed ID: 28554502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of recombinant H5 vaccines delivered in ovo or day of age in commercial broilers against the 2015 U.S. H5N2 clade 2.3.4.4c highly pathogenic avian Influenza virus.
    Kapczynski DR; Chrzastek K; Shanmugasundaram R; Zsak A; Segovia K; Sellers H; Suarez DL
    Virol J; 2023 Dec; 20(1):298. PubMed ID: 38102683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homologous and heterologous antigenic matched vaccines containing different H5 hemagglutinins provide variable protection of chickens from the 2014 U.S. H5N8 and H5N2 clade 2.3.4.4 highly pathogenic avian influenza viruses.
    Kapczynski DR; Pantin-Jackwood MJ; Spackman E; Chrzastek K; Suarez DL; Swayne DE
    Vaccine; 2017 Nov; 35(46):6345-6353. PubMed ID: 28456525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a Recombinant Turkey Herpesvirus AI (H5) Vaccine in Preventing Transmission of Heterologous Highly Pathogenic H5N8 Clade 2.3.4.4b Challenge Virus in Commercial Broilers and Layer Pullets.
    Palya V; Tatár-Kis T; Walkóné Kovács E; Kiss I; Homonnay Z; Gardin Y; Kertész K; Dán Á
    J Immunol Res; 2018; 2018():3143189. PubMed ID: 30584541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a recombinant HVT-H5 vaccine against challenge with two genetically divergent Indonesian HPAI H5N1 strains.
    Soejoedono RD; Murtini S; Palya V; Felföldi B; Mató T; Gardin Y
    Avian Dis; 2012 Dec; 56(4 Suppl):923-7. PubMed ID: 23402113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of an inactivated avian influenza H5N1 vaccine against an African strain of HPAI H5N8 (clade 2.3.4.4 B).
    Maartens LH; Frizzo da Silva L; Dawson S; Love N; Erasmus BJ
    Avian Pathol; 2023 Jun; 52(3):176-184. PubMed ID: 37079321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of commercial turkeys following inactivated or recombinant H5 vaccine application against the 2015U.S. H5N2 clade 2.3.4.4 highly pathogenic avian influenza virus.
    Kapczynski DR; Sylte MJ; Killian ML; Torchetti MK; Chrzastek K; Suarez DL
    Vet Immunol Immunopathol; 2017 Sep; 191():74-79. PubMed ID: 28895870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single dose of inactivated oil-emulsion bivalent H5N8/H5N1 vaccine protects chickens against the lethal challenge of both highly pathogenic avian influenza viruses.
    Ibrahim M; Zakaria S; Bazid AI; Kilany WH; Zain El-Abideen MA; Ali A
    Comp Immunol Microbiol Infect Dis; 2021 Feb; 74():101601. PubMed ID: 33307456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Clade 2.3.2 H5-Recombinant Baculovirus Vaccine in Protecting Muscovy and Pekin Ducks from Clade 2.3.4.4 H5N8 Highly Pathogenic Avian Influenza Infection.
    Sultan HA; Arafa AE; Talaat S; Gaballa AA; Kilany WH; Elfeil WK; Shehata AA; Amarin N
    Avian Dis; 2019 Mar; 63(sp1):219-229. PubMed ID: 31713400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of commercial recombinant HVT vaccines against a North American clade 2.3.4.4b H5N1 highly pathogenic avian influenza virus in chickens.
    Lee J; Lee CW; Suarez DL; Lee SA; Kim T; Spackman E
    PLoS One; 2024; 19(7):e0307100. PubMed ID: 39012858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrepancies in the efficacy of H5 inactivated avian influenza vaccines in specific-pathogen-free chickens against challenge with the Egyptian H5N8 clade 2.3.4.4 Group B virus isolated in 2018.
    El-Moeid AA; El-Deeb AH; Elsaied MF; Soliman RA; El-Safty MM; Hussein HA
    Vet World; 2021 Aug; 14(8):2131-2141. PubMed ID: 34566331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection conferred by recombinant turkey herpesvirus avian influenza (rHVT-H5) vaccine in the rearing period in two commercial layer chicken breeds in Egypt.
    Kilany W; Dauphin G; Selim A; Tripodi A; Samy M; Sobhy H; VonDobschuetz S; Safwat M; Saad M; Erfan A; Hassan M; Lubroth J; Jobre Y
    Avian Pathol; 2014; 43(6):514-23. PubMed ID: 25245772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of three hemagglutinin-based vaccines for the experimental control of a panzootic clade 2.3.4.4b A(H5N8) high pathogenicity avian influenza virus in mule ducks.
    Niqueux É; Flodrops M; Allée C; Lebras MO; Pierre I; Louboutin K; Guillemoto C; Le Prioux A; Le Bouquin-Leneveu S; Keïta A; Amelot M; Martenot C; Massin P; Cherbonnel-Pansart M; Briand FX; Schmitz A; Cazaban C; Dauphin G; Delquigny T; Lemière S; Watier JM; Mogler M; Tarpey I; Grasland B; Eterradossi N
    Vaccine; 2023 Jan; 41(1):145-158. PubMed ID: 36411134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of rHVT-AI vector vaccine in broilers with passive immunity against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains.
    Rauw F; Palya V; Gardin Y; Tatar-Kis T; Dorsey KM; Lambrecht B; van den Berg T
    Avian Dis; 2012 Dec; 56(4 Suppl):913-22. PubMed ID: 23402112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.